Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2Kb

Nature Immunology

Volumn 4, Issue 12, 2003, Pages 1213-1222

  Dam, Julie ^a   Guan, Rongjin ^a   Natarajan, Kannan ^b   Dimasi, Nazzareno ^a,e   Chlewicki, Lukasz K ^c   Kranz, David M ^c   Schuck, Peter ^d   Margulies, David H ^b   Mariuzza, Roy A ^a  

^a UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CROSS REACTION; CRYSTAL STRUCTURE; DIMERIZATION; EXPERIMENTAL MODEL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN PURIFICATION;

ANIMALS; ANTIGENS, LY; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; H-2 ANTIGENS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MAJOR HISTOCOMPATIBILITY COMPLEX; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; SUBSTRATE SPECIFICITY;

EID: 0347382594     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1006     Document Type: Article

References (50)

1. McQueen, K.L. & Parham, P. Variable receptors controlling activation and inhibition of NK cells. Curr. Opin. Immunol. 14, 615-621 (2002).
2. Plougastel, B.F.M. & Yokoyama, W.M. Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 3, 304-316 (2003).
3. Natarajan, K., Dimasi, N., Wang, J., Mariuzza, R.A. & Margulies, D.H. Structure and function of natural killer cell receptors: multiple molecular solutions to self, non-self discrimination. Annu. Rev. Immunol. 20, 853-885 (2002).
4. Vivier, E., Tomasello, E. & Paul, P. Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition? Curr. Opin. Immunol. 14, 306-311 (2002).
5. Anderson, S.K., Ortaldo, J.R. & McVicar, D.W. The ever-expanding Ly49 gene family: repertoire and signaling. Immunol. Rev. 181, 79-89 (2001).
6. Arase, H., Mocarski, E.S., Campbell, A.E., Hill, A.B. & Lanier, L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296, 1323-1326 (2002).
7. Smith, H.R. et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99, 8826-8831 (2002).
8. Franksson, L. et al. Peptide dependency and selectivity of the NK inhibitory receptor Ly-49C. Eur. J. Immunol. 29, 2748-2758 (1999).
9. Hanke, T. et al. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11, 67-77 (1999).
10. Boyington, J.C., Brooks, A.G. & Sun, P.D. Structure of killer cell immunoglobulin-like receptors and their recognition of the class I MHC molecules. Immunol. Rev. 181, 66-78 (2001).
11. Li, P. et al. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat. Immunol. 2, 443-451 (2001).
12. Tormo, J., Natarajan, K., Margulies, D.H. & Mariuzza, R.A. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 402, 623-631 (1999).
13. Matsumoto, N., Mitsuki, M., Tajima, K., Yokoyama, W.M. & Yamamoto, K. The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand. J. Exp. Med. 193, 147-158 (2001).
14. 2-microglobulin. J. Biol. Chem. 277, 1433-1442 (2002).
15. Kåse, A., Johansson, M.H., Olsson-Alheim, M.Y., Kärre, K. & Höglund, P. External and internal calibration of the MHC class I-specific receptor Ly49A on murine natural killer cells. J. Immunol. 161, 6133-6138 (1998).
16. Andersson, M. et al. MHC class I mosaic mice reveal insights into control of Ly49C inhibitory receptor expression in NK cells. J. Immunol. 161, 6475-6479 (1998).
17. + natural killer (NK) cells precludes ligand uptake from environmental cells. J. Exp. Med. 194, 1531-1539 (2001).
18. Chung, D.H. et al. Mapping the ligand of the NK inhibitory receptor Ly49A on living cells. J. Immunol. 165, 6922-6932 (2000).
19. d: identification of a site distinct from the TCR site. Immunity 11, 591-601 (1999).
20. Sundbäck, J., Achour, A., Michaesson, J., Lindstrom, H. & Kärre, K. NK cell inhibitory receptor Ly-49C residues involved in MHC class I binding. J. Immunol. 168, 793-800 (2002).
21. Boder, E.T. & Wittrup, K.D. Yeast surface display for screening combinatorial polypeptide libraries. Nat, Biotech. 15, 553-557 (1997).
22. Kieke, M.C. et al. Selection of functional T cell receptor mutants from a yeast surface-display library. Proc. Natl. Acad. Sci. USA 96, 5651-5656 (1999).
23. Dimasi, N. et al. Crystal structure of the Ly491 natural killer cell receptor reveals variability in dimerization mode within the Ly49 family. J. Mol. Biol. 320, 573-585 (2002).
24. Shusta, E.V., Kieke, M.C., Parke, E., Kranz, D.M. & Wittrup, K.D. Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency. J. Mol. Biol. 292, 949-956 (1999).
25. Garcia De La Torre, J., Huertas, M.L. & Carrasco, B. Calculation of hydrodynamic properties of globular proteins from their atomic-level structure. Biophys. J. 78, 719-730 (2000).
26. Daniels, M.A. et al. CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity 15, 1051-1061 (2001).
27. Lawrence, M.C. & Colman, P.M. Shape complementarity at protein-protein interfaces. J. Mol. Biol. 234, 946-950 (1993).
28. Wolan, D.W. et al.Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 Å. Nat. Immunol. 2, 248-254 (2001).
29. Radaev, S., Rostro, B., Brooks, A.G., Colonna, M. & Sun, P. Conformational plasticity revealed by the co-crystal structure of the activating NK receptor NKG2D and its MHC-like ligand ULBP. Immunity 15, 1039-1049 (2001).
30. Rudolph, M.G. & Wilson, I.A. The specificity of TCR/pMHC interaction. Curr. Opin. Immunol. 14, 52-65 (2002).
31. Sundberg, E.J., Li, Y. & Mariuzza, R.A. So many ways of getting in the way: diversity in the molecular architecture of superantigen-dependent T-cell signaling complexes. Curr. Opin. Immunol. 14, 36-44 (2002).
32. b. Science 257, 919-927 (1992).
33. b-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc. Natl. Acad. Sci. USA 92, 2479-2483 (1995).
34. Sundberg, E.J. & Mariuzza, R.A. Molecular recognition in antigen-antibody complexes. Adv. Protein Chem. 61, 119-160 (2002).
35. Madden, D.R. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13, 587-622 (1995).
36. Gao, G.F. et al. Crystal structure of the complex between human CD8αα and HLA-A2. Nature 387, 630-634 (1997).
37. b. Immunity 9, 519-530 (1998).
38. Ahn, V.E., Faull, K.F., Whitelegge, J.P., Fluharty, A.L. & Prive, G.G. Crystal structure of saposin B reveals a dimeric shell for lipid binding. Proc. Natl. Acad. Sci. USA 100, 38-43 (2003).
39. Chow, D., He, X., Snow, A.L., Rose-John, S. & Garcia, K.C. Structure of an extracellular gp130 cytokine receptor signaling complex. Science 291, 2150-2155 (2001).
40. Reich, Z. et al. Ligand-specific oligomerization of T-cell receptor molecules. Nature 387, 617-620 (1997).
41. Alam, S.M. et al. Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands. Immunity 10, 227-237 (1999).
42. Sakihama, T., Smolyar, A. & Reinherz, E.L. Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120. Proc. Natl. Acad. Sci. USA 92, 6444-6448 (1995).
43. Wu, H., Kwong, P.D. & Hendrickson, W.A. Dimeric association and segmental variability in the structure of CD4. Nature 387, 527-530 (1997).
44. Baker, B.M. & Wiley, D.C. αβ T cell receptor ligand-specific oligomerization revisited. Immunity 14, 681-692 (2001).
45. Wang, J.H. et al. Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule. Proc. Natl. Acad. Sci. USA 98, 10799-10804 (2001).
46. Holler, P.D. & Kranz, D.M. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity 18, 255-264 (2003).
47. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
48. Navaza, J. AMoRe: an automated package for molecular replacement. Acta Crystallogr. A 50, 157-163 (1994).
49. Brünger, A.T. et al. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905-921 (1998).
50. McRee, D.E. XtalView/Xfit. A versatile program for manipulating atomic coordinates and electron density. J. Struct. Biol. 125, 156-165 (1999).